While drugs can help manage symptoms, there is currently no cure for Lewy Body Dementia. Despite the challenges, Kent has ...

Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of ...

The cumulative use of strong anticholinergics is associated with an increased risk for dementia in a dose-response pattern; ...

Researchers have devised a new way to illuminate the previously invisible oligomer clumps driving Parkinson’s disease.

Nervous disorders like Parkinson's or dementia often manifest in unlikely ways such as weakness in limbs. Recognising these symptoms is crucial for diagnosis.

The VasCog-2-WSO criteria revise the original VasCog criteria for diagnosing VCID, offering additional guidance on neuroimaging and fluid biomarkers.

ACADIA Pharmaceuticals Inc. (($ACAD)) announced an update on their ongoing clinical study. Study Overview: ACADIA Pharmaceuticals Inc. is ...

Researchers have finally seen and measured the tiny alpha-synuclein oligomers that may ignite Parkinson’s disease. With the ...

Can’t remember what you needed to buy when out for grocery shopping? Or need a minute to pinpoint the immediate neighbor’s name? When someone forgets where they put their keys or momentarily draws a ...

Mr. Quigley most recently led McKinsey & Company’s Private Capital practice and previously led various Life Sciences practices at the ...

Learn more about whether ACADIA Pharmaceuticals Inc. or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The senior prom is specialized for dementia patients and caregivers, part of "memory cafes" to foster community and cognitive ...